Dr. Gerald Diaz @GeraldMD
29.3M 13.9K 7.3K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
26 results
Initiation of ART in HIV patients with Opportunistic Infections
 β€’ Pulmonary TB and CD4 cell count
patients with Opportunistic ... Infections β€’ ... of starting OI treatment ... Therapy #HAART #HIV #Opportunistic ... #Infections #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 β€’ Antimicrobial
Bacterial Enteric Infections ... (CDI): β€’ Vancomycin ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... of mode of HIV infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 β€’ Fluid
Patients with CD4 ... Sustained increase in CD4 ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)β†’Activation of CD8 T cells (IFN-y) β†’ Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... Triggering factor (infection ... β†’Activation of CD8 ... Unknown cause Treatment ... diagnosis #management #treatment
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 β€’
leishmaniasis and CD4 ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Disease Note: Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for effective treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 β€’ CMV end-organ disease is best
ART to maintain CD4 ... whenever feasible, treatment ... effective for treatment ... #management #opportunistic ... #pharmacology